Key Highlights
- Q3 net revenue reached an all-time high of $206.7M, marking an 11% year-over-year increase and surpassing analyst projections of $201.35M
- Company posted adjusted earnings of $0.02 per share, defying consensus expectations of a -$0.14 loss
- Cannabis division expanded 19% to $64.8M, fueled by a remarkable 73% spike in international cannabis sales
- Adjusted EBITDA climbed 19% to $10.7M; company maintains fiscal 2026 outlook of $62M–$72M
- Company finalized BrewDog acquisition for approximately £40M and unveiled strategic Carlsberg collaboration launching in 2027
Tilray Brands delivered a record-setting performance in its third quarter of fiscal 2026, achieving net revenue of $206.7 million. This represents an 11% increase compared to the $185.8 million generated during the corresponding period last year, exceeding analyst forecasts.
The real story was the earnings shock. Wall Street had anticipated a 14-cent per share loss. Instead, Tilray delivered a positive $0.02 adjusted earnings per share. This significant outperformance typically triggers market reactions, and TLRY responded with an 8.01% surge.
The company reported a net loss of $25.2 million for the quarter. While losses are never ideal, this represents a dramatic turnaround from the staggering $793.5 million loss posted in the prior-year quarter.
Gross profit reached $55.0 million, reflecting a 6% year-over-year gain, while the consolidated gross margin stood at 27%.
The cannabis division emerged as a standout performer. Total cannabis revenue expanded 19% to reach $64.8 million. International cannabis net revenue experienced explosive growth of 73%, while cannabis flower sales volume doubled compared to the same quarter last year.
Canadian adult-use and medical cannabis net revenue increased 8%, solidifying Tilray’s position as the top cannabis revenue generator in Canada.
The distribution division also delivered impressive results. It achieved a Q3 record of $83.0 million in net revenue, while distribution gross profit rose to $10.0 million and margins improved to 12%.
Tilray also finalized its Project 420 synergy initiative during the quarter. This program generated approximately $33 million in annualized cost reductions.
Strategic Acquisitions and Partnerships Expand Global Footprint
Following quarter-end, Tilray finalized its acquisition of BrewDog, the prominent UK craft beer brand, for roughly £40 million in cash. CEO Irwin Simon emphasized that this transaction enables the company to establish a “scaled global beverage platform.”
Additionally, Tilray unveiled a strategic partnership with Carlsberg, scheduled to commence in 2027. According to the company, this collaboration extends its footprint across Europe, the Middle East, Australia, Asia-Pacific, and the United States.
Adjusted EBITDA for the third quarter totaled $10.7 million, representing a 19% increase from the $9.0 million recorded in the prior-year period.
Management Maintains Full-Year Outlook
Executives reaffirmed their fiscal 2026 adjusted EBITDA guidance of $62 million to $72 million. This projection reflects anticipated growth of 13% to 31% versus fiscal year 2025.
Analyst sentiment on TLRY currently stands at Hold, based on one Buy rating and five Hold ratings issued over the last three months. The consensus price target is $8.97, suggesting approximately 38.64% potential upside from current trading levels.
Notwithstanding the strong Q3 results, TLRY shares remain down 28.35% year-to-date and have declined 0.68% over the trailing 12-month period.


